SOCS1 and SOCS3 Target IRF7 Degradation To Suppress TLR7-Mediated Type I IFN Production of Human Plasmacytoid Dendritic Cells

Type I IFN production of plasmacytoid dendritic cells (pDCs) triggered by TLR-signaling is an essential part of antiviral responses and autoimmune reactions. Although it was well-documented that members of the cytokine signaling (SOCS) family regulate TLR-signaling, the mechanism of how SOCS proteins regulate TLR7-mediated type I IFN production has not been elucidated yet. In this article, we show that TLR7 activation in human pDCs induced the expression of SOCS1 and SOCS3. SOCS1 and SOCS3 strongly suppressed TLR7-mediated type I IFN production. Furthermore, we demonstrated that SOCS1- and SOCS3-bound IFN regulatory factor 7, a pivotal transcription factor of the TLR7 pathway, through the SH2 domain to promote its proteasomal degradation by lysine 48-linked polyubiquitination. Together, our results demonstrate that SOCS1/3-mediated degradation of IFN regulatory factor 7 directly regulates TLR7 signaling and type I IFN production in pDCs. This mechanism might be targeted by therapeutic approaches to either enhance type I IFN production in antiviral treatment or decrease type I IFN production in the treatment of autoimmune diseases.

[1]  Joanne E. Simpson,et al.  Plasmacytoid Dendritic Cells Respond Directly to Apoptotic Cells by Secreting Immune Regulatory IL-10 or IFN-α , 2016, Frontiers in immunology.

[2]  P. Tewary,et al.  IRF5 and IRF8 modulate the CAL‐1 human plasmacytoid dendritic cell line response following TLR9 ligation , 2016, European journal of immunology.

[3]  S. Klaschik,et al.  Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1 , 2015, Mediators of inflammation.

[4]  Shanshan Yan,et al.  TRIM35 negatively regulates TLR7‐ and TLR9‐mediated type I interferon production by targeting IRF7 , 2015, FEBS letters.

[5]  H. Shu,et al.  FoxO1 Negatively Regulates Cellular Antiviral Response by Promoting Degradation of IRF3* , 2013, The Journal of Biological Chemistry.

[6]  G. Barber,et al.  IRF7: activation, regulation, modification and function , 2011, Genes and Immunity.

[7]  T. Bieber,et al.  Tetraspanins CD9 and CD81 are molecular partners of trimeric FcɛRI on human antigen‐presenting cells , 2011, Allergy.

[8]  A. Dalpke,et al.  Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  G. Hayward,et al.  The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. , 2010, Immunity.

[10]  A. Lézin,et al.  HTLV-1 Evades Type I Interferon Antiviral Signaling by Inducing the Suppressor of Cytokine Signaling 1 (SOCS1) , 2010, PLoS pathogens.

[11]  J. Clements,et al.  Suppressor of Cytokine Signaling 3 Inhibits Antiviral IFN-β Signaling To Enhance HIV-1 Replication in Macrophages , 2010, The Journal of Immunology.

[12]  R. Higgs,et al.  Self Protection from Anti-Viral Responses – Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors , 2010, PloS one.

[13]  B. Beutler,et al.  Intracellular toll-like receptors. , 2010, Immunity.

[14]  G. Hartmann,et al.  Human Plasmacytoid Dendritic Cells Support Th17 Cell Effector Function in Response to TLR7 Ligation , 2009, The Journal of Immunology.

[15]  Zhan-qing Zhang,et al.  HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. , 2009, Molecular immunology.

[16]  T. Krunkosky,et al.  Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. , 2009, Viral immunology.

[17]  S. Akira,et al.  Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins , 2009, Cell Research.

[18]  R. Coffman,et al.  Signalling pathways leading to IFN‐α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications , 2009, Journal of internal medicine.

[19]  Min Zhang,et al.  Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3 , 2008, Cell Research.

[20]  R. Tripp,et al.  Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15) , 2008, Virology Journal.

[21]  J. Tavernier,et al.  The many faces of the SOCS box. , 2008, Cytokine & growth factor reviews.

[22]  Courtney R. Plumlee,et al.  Inteferons pen the JAK-STAT pathway. , 2008, Seminars in cell & developmental biology.

[23]  R. Rottapel,et al.  Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins , 2008, Immunological reviews.

[24]  R. Higgs,et al.  The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-β Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF31 , 2008, The Journal of Immunology.

[25]  Hiu Kiu,et al.  SOCS regulation of the JAK/STAT signalling pathway. , 2008, Seminars in cell & developmental biology.

[26]  E. Buchberger,et al.  Neutralizing Type I IFN Antibodies Trigger an IFN-Like Response in Endothelial Cells1 , 2008, The Journal of Immunology.

[27]  J. Ward,et al.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. , 2007, Immunity.

[28]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[29]  K. Honda,et al.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.

[30]  K. Honda,et al.  Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors , 2006 .

[31]  P. Cohen,et al.  Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. , 2006, Molecular endocrinology.

[32]  A. Satterthwaite,et al.  Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication , 2006, Science.

[33]  Shizuo Akira,et al.  Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1 , 2006, Nature Immunology.

[34]  R. Norton,et al.  The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. , 2006, Molecular cell.

[35]  C. Garlanda,et al.  Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL‐10 and inhibition by IFN‐γ , 2006, Journal of leukocyte biology.

[36]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.

[37]  M. Tomonaga,et al.  A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma , 2005, International journal of hematology.

[38]  T. Bieber,et al.  Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. , 2004, The Journal of allergy and clinical immunology.

[39]  J. Johnston,et al.  SOCS: role in inflammation, allergy and homeostasis. , 2004, Trends in immunology.

[40]  I. Kawase,et al.  SOCS‐1 suppresses TNF‐α‐induced apoptosis through the regulation of Jak activation , 2004 .

[41]  T. Suzutani,et al.  Induction of Suppressor of Cytokine Signaling-3 by Herpes Simplex Virus Type 1 Contributes to Inhibition of the Interferon Signaling Pathway , 2004, Journal of Virology.

[42]  M. Kubo,et al.  Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. , 2003, Immunity.

[43]  K. Heeg,et al.  TLR-induced negative regulatory circuits: role of suppressor of cytokine signaling (SOCS) proteins in innate immunity. , 2003, Vaccine.

[44]  Donald Metcalf,et al.  SOCS3 negatively regulates IL-6 signaling in vivo , 2003, Nature Immunology.

[45]  P. Heinrich,et al.  IFN‐α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling‐3 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Kenji Nakanishi,et al.  SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.

[47]  K. Heeg,et al.  Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs1 , 2001, The Journal of Immunology.

[48]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[49]  M. Clare-Salzler,et al.  Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .

[50]  W. Cao,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 22, 2013. For personal use , 2006 .

[51]  K. Honda,et al.  Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. , 2006, Immunity.

[52]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[53]  B. Beutler,et al.  TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY , 2005 .

[54]  B. Beutler,et al.  Type I interferons (alpha/beta) in immunity and autoimmunity. , 2005, Annual review of immunology.

[55]  I. Kawase,et al.  SOCS-1 suppresses TNF-alpha-induced apoptosis through the regulation of Jak activation. , 2004, International immunology.

[56]  M. Billah,et al.  Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.